This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.This, the neurodevelopmental follow up phase of the main trial, will determine if survivors of severe twin twin transfusion have improved outcome if they received laser coagulation of common placental blood vessels compared to survivors who underwent the standard treatment of serial removals of amniotic fluid. Neurodevelopment is being assessed at 18-22 months of age, corrected for prematurity.
Showing the most recent 10 out of 589 publications